Pancreatic Cancer Research

ResearcherUniversity of Oklahoma Health Sciences CenterActive in the last 2 years

Ravi Kumar Thakur

Matched on ORCID iD 0000-0003-2505-9757; OpenAlex author ID A5072304509, A5140260118. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper · 2026: 2 papers

Papers 10

  1. KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-1984↗
  2. Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. Co-author DOI 10.1186/s12943-025-02340-8↗
  3. Tumor-stromal metabolic crosstalk in pancreatic cancer. Co-author DOI 10.1016/j.tcb.2025.04.007↗
  4. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  5. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  6. The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Co-author DOI 10.1073/pnas.2315509121↗
  7. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. First author DOI 10.1016/j.canlet.2022.215981↗
  8. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  9. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗
  10. Molecular Subtypes of Pancreatic Cancer: A Proteomics Approach. Co-author DOI 10.1158/1078-0432.ccr-21-0640↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pankaj Kumar Singh · 9 shared papers, 2021–2026 · strength 1.70
  2. Kamiya Mehla · 7 shared papers, 2021–2026 · strength 1.36
  3. Surendra Kumar Shukla · 8 shared papers, 2021–2026 · strength 1.28
  4. Chunbo He · 7 shared papers, 2021–2026 · strength 1.09
  5. Nina V. Chaika · 6 shared papers, 2021–2024 · strength 0.84
  6. Tuo Hu · 5 shared papers, 2021–2026 · strength 0.81
  7. Michael Anthony Hollingsworth · 5 shared papers, 2022–2026 · strength 0.80
  8. Ryan J. King · 5 shared papers, 2021–2026 · strength 0.71
  9. Divya Murthy · 5 shared papers, 2021–2024 · strength 0.67
  10. Kuldeep Singh Attri · 5 shared papers, 2021–2024 · strength 0.67
  11. Sai Sundeep Kollala · 4 shared papers, 2023–2026 · strength 0.66
  12. Scott E. Mulder · 5 shared papers, 2021–2024 · strength 0.65
  13. Nicholas James Mullen · 3 shared papers, 2021–2025 · strength 0.62
  14. Susanna Varkey Ulahannan · 3 shared papers, 2024–2026 · strength 0.50
  15. Voddu Suresh · 2 shared papers, 2024–2026 · strength 0.41
  16. Aneesha Dasgupta · 3 shared papers, 2022–2024 · strength 0.40
  17. Paul M. Grandgenett · 3 shared papers, 2022–2024 · strength 0.40
  18. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  19. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  20. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  21. Robert Powers · 2 shared papers, 2024 · strength 0.28
  22. Teklab Gebregiworgis · 2 shared papers, 2024 · strength 0.28
  23. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  24. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  25. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.